LFood and drug retail
Loblaw Companies
- Price
- CA$71.45
- Discount category
- Far above intrinsic value
- Analysts
- Bullish
- Next earnings
- Feb 19 · · estimated
- Pick status
- Research only
In short
- Thesis
- Investors pay a premium for the steady earnings growth and buybacks of Loblaw, and only several years of EPS growth near its long-term target can earn it.
- Gap
- Slow. Only several years of adjusted EPS growth near the target of 8% to 10% a year can earn the premium.
Company guidance: 2026 adjusted EPS growth in the high single digits and about $2.4 billion of capital expenditures (, Q3 2026 report to shareholders)
Price history
About
Loblaw Companies (Loblaw) is the largest food and pharmacy retailer in Canada. It operates supermarkets, hard discount stores and drug stores under banners such as Loblaws, Real Canadian Superstore, No Frills, Maxi, T&T and Shoppers Drug Mart, and it sells its own brands President's Choice and no name. Its PC Optimum loyalty program had more than 18 million active members in 2025. At October 10, 2026, Loblaw had 2,540 stores and 74.2 million square feet of retail space, and in Q2 2026 it opened its first T&T store in California.
Loblaw also has businesses in supply chain services, retail media and data, and Lifemark health clinics. On July 1, 2026, it sold President's Choice Bank to EQB Inc. and now owns about 19.9% of EQB. In 2025, a year with one extra week, revenue was C$63,903 million. George Weston Limited owns about 52.6% of the common shares.
The shares trade on the Toronto Stock Exchange. The head office is in Brampton, Ontario. Per Bank is President and Chief Executive Officer.
Thesis
Loblaw trades above its intrinsic value because investors pay for its steady earnings growth, its strong position in Canadian food and pharmacy retail and its large share buybacks. Adjusted diluted EPS from continuing operations rose 11.4% in the first 40 weeks of 2026, and Loblaw bought back 27.3 million shares for C$1,724 million in that time. At its Investor Day on September 9, 2026, Loblaw set a long-term target of adjusted EPS growth of about 8% to 10% a year.
For the shares to earn this price, three things must be true. Discount banners and Shoppers Drug Mart must keep growing their sales, although Food Retail same-store sales grew only 0.6% in Q3 2026 and store traffic fell. Retail earnings must grow faster than sales, as the 2026 outlook says.
The new growth businesses and the share of EQB income must add to earnings, so that their contribution doubles by 2031. The 2026 results and the 2027 outlook, expected in February 2027, are the next test. Slower food sales, more price competition or new rules on grocery prices can make the premium hard to keep.
Checkpoints
- Jul 30, 2026PassedQ2 2026 results and the 2026 outlookAdjusted EPS growth of 8% or more and a kept outlook pass; a lower outlook fails.Outcome: Adjusted EPS rose 11.9% to C$0.66, and Loblaw kept its 2026 outlook.
- Nov 19, 2026PassedQ3 2026 results, the first quarter without President's Choice BankAdjusted EPS growth from continuing operations of 8% or more and positive Food Retail same-store sales pass; lower adjusted EPS fails.Outcome: Adjusted diluted EPS from continuing operations rose 15.6% to C$0.74, and Food Retail same-store sales grew 0.6%.
- Feb 19, 2027 · est.Pending2026 results and the 2027 outlook2026 adjusted EPS growth in the high single digits and a 2027 outlook in line with the 8% to 10% framework pass; a lower outlook fails.
Recent events
- November 19, 2026Loblaw reported Q3 2026 results, the first quarter without President's Choice Bank. Retail sales rose 3.6% to C$19,857 million, with Food Retail same-store sales growth of 0.6% and Drug Retail same-store sales growth of 4.8%. Adjusted diluted EPS from continuing operations rose 15.6% to C$0.74, and total adjusted diluted EPS rose 8.8%. Net earnings included a gain of C$401 million on the sale of PC Financial. Loblaw bought back 8.3 million shares for C$524 million in the quarter and kept its 2026 outlook of adjusted EPS growth in the high single digits.
- November 18, 2026Loblaw sold its interest in QHR Technologies, a maker of medical record software, to LGI Healthcare Solutions for about C$236 million in cash. Loblaw will record the gain in Q4 2026.
- September 30, 2026The Competition Bureau started an investigation of minimum advertised pricing policies of large consumer goods suppliers. Loblaw said that it supports this investigation and the Bureau's review of competition across the food supply chain.
Show 4 older eventsHide older events
- September 9, 2026At its Investor Day, Loblaw set a long-term financial framework that targets adjusted EPS growth of about 8% to 10% a year. It expects supply chain services, retail media and data, Lifemark, the T&T expansion in the United States and the EQB income to give about 10% of operating income in 2026, and their contribution to double by 2031.
- July 30, 2026Loblaw reported Q2 2026 results. Retail sales rose 4.1% to C$15,046 million, with Food Retail same-store sales growth of 1.6% and Drug Retail same-store sales growth of 4.6%. Adjusted EPS rose 11.9% to C$0.66. Loblaw bought back 8.8 million shares for C$552 million in the quarter and kept its 2026 outlook of adjusted EPS growth in the high single digits.
- July 1, 2026Loblaw completed the sale of President's Choice Bank and related businesses to EQB Inc. for C$1,234 million, which included 7.2 million EQB shares worth C$963 million and C$235 million in cash. Loblaw now owns about 19.9% of EQB and expects a gain of about C$375 million before tax in Q3 2026.
- May 6, 2026Loblaw reported Q1 2026 results. Net earnings available to common shareholders rose 18.1% to C$594 million, or C$0.50 per share, and adjusted EPS rose 10.6% to C$0.52. It opened 5 hard discount stores and 8 drug stores.
Risks
Bull case: Adjusted diluted EPS rose 11.4% in the first 40 weeks of 2026, and the long-term target of about 8% to 10% a year with C$1,724 million of repurchases can keep earnings per share growing.
- Food retail in Canada is very competitive. Other grocers, discount stores and online sellers compete on price, and more sales in discount stores can lower margins. In Q3 2026, Food Retail traffic fell on a same-store basis.
- Changes to laws and rules, for example on prices, supplier terms or competition, can limit margins.
- Drug Retail depends on prescription drug prices that governments set. A reduction of generic drug prices or of professional allowances can lower earnings.
- Loblaw now owns about 19.9% of EQB. Its share of EQB income depends on the results of a bank, which can change with credit losses and interest rates. In Q3 2026, the first credit loss provisions of EQB on the PC Financial loans gave Loblaw a loss of C$26 million from this investment.
- George Weston Limited owns about 52.6% of the shares and controls Loblaw. Its interests can differ from those of other shareholders.
Key statistics
- Market cap
- CA$83B
- Shares of Apr 30, 2026
- Dividend yield
- 0.9%
- Current annual rate, at the price of Nov 20, 2026
- 52-week range
- CA$58.23 – CA$71.45
- To Nov 12, 2026
- Beta
- 0.16
- Vs S&P 500, 5 years monthly, to Oct 30, 2026
- Average volume
- 1.2M
- 3 months, to Nov 12, 2026
Check the numbers:ExchangeGoogle FinanceYahoo Finance
Balance sheet
- Cash
- CA$1.0B
- Debt
- CA$6.1B
- Net debt
- CA$5.1B
- Credit line
- CA$1.4B
- undrawn, to March 2030
Cash against debt
debt covered by cashnet debt CA$5.1B
Credit ratings
- S&P BBB+ · stable
Loblaw funds itself with cash flow, debentures and leases. At October 10, 2026, cash and cash equivalents were C$1,049 million, and Loblaw had no short-term investments. Long-term debt was C$6,103 million: debentures of C$5,201 million, independent funding trusts of C$767 million and C$150 million drawn on the committed credit facility. None of it was due within one year. Lease liabilities were C$10,821 million. Total debt excluding leases, with certain other liabilities, was C$6,431 million. Debt to rolling year adjusted EBITDA, as Loblaw measures it, was 2.3 times. The committed credit facility of C$1.5 billion ends on March 27, 2030, and C$1,350 million of it was undrawn. S&P rates the issuer BBB+ with a stable outlook. The investment in EQB and other equity-accounted investments was C$1,262 million. In the first 40 weeks of 2026, free cash flow from continuing operations was C$1,612 million, and Loblaw bought back 27.3 million shares for C$1,724 million. 1,150,054,561 shares were outstanding at October 10, 2026. On November 18, 2026, the sale of QHR Technologies gave about C$236 million in cash. The quarterly dividend is C$0.155183 per share, and the next one is payable on December 30, 2026.
As of
Show 2 sourcesHide sources
Dividends
- Dividend yield
- 0.9% (current annual rate, at today’s price of CA$71.45)
- Paid per share
- CA$0.592 in the last 12 months (4 payments)
- Current annual rate
- CA$0.62 (CA$0.155 × 4 a year)
- Latest ex-dividend date
- September 15, 2026, CA$0.155 per share
Dividends per share by year
| 2016 | CA$0.207 | |
|---|---|---|
| 2017 | CA$0.215 | |
| 2018 | CA$0.2466 | |
| 2019 | CA$0.31 | |
| 2020 | CA$0.32 | |
| 2021 | CA$0.35 | |
| 2022 | CA$0.395 | |
| 2023 | CA$0.4358 | |
| 2024 | CA$0.4963 | |
| 2025 | CA$0.5513 |
From 2020 to 2025, the dividend grew by about 11.5% a year. From 2016 to 2025, the dividend grew by about 11.5% a year.
Source: company filings and market data, read on November 13, 2026. The ex-dividend date is the first day a buyer no longer gets the next payment.
Questions about Loblaw Companies
What does Loblaw Companies do?
Loblaw Companies (Loblaw) is the largest food and pharmacy retailer in Canada. Its market cap is CA$83B at the current price of CA$71.45.
When does Loblaw Companies report earnings next?
This is an estimate: Loblaw Companies may report on February 19, 2027. It last reported results on November 19, 2026.
Is Loblaw Companies stock below its intrinsic value?
Loblaw Companies stock is far above intrinsic value. This is general information, not advice.
What changed recently at Loblaw Companies?
The latest update is from November 19, 2026. Loblaw reported Q3 2026 results, the first quarter without President's Choice Bank.
What are the main risks for Loblaw Companies?
Food retail in Canada is very competitive. Changes to laws and rules, for example on prices, supplier terms or competition, can limit margins. Drug Retail depends on prescription drug prices that governments set.
How much debt and cash does Loblaw Companies have?
At October 10, 2026, Loblaw Companies had CA$6.1B of debt and CA$1.0B of cash.
Does Loblaw Companies pay a dividend?
Yes. The current annual dividend of Loblaw Companies is CA$0.62 per share. That is a dividend yield of 0.9% at the current price of CA$71.45. In the last 12 months, it paid CA$0.592 per share (0.8%). The latest ex-dividend date was September 15, 2026.
Similar companies
- DANOYDanoneShares: Weak consumer, Regulation and courts
- Intrinsic value
- Below intrinsic value
- Gap
- Can close
- WMMVYWalmart de MéxicoShares: Weak consumer, Regulation and courts
- Intrinsic value
- Close to intrinsic value (AI estimate)
- Gap
- Slow
- DGDollar GeneralShares: Weak consumer, Regulation and courts
- Intrinsic value
- Close to intrinsic value
- Gap
- Can close
- ABEVAmbevShares: Regulation and courts, Weak consumer
- Intrinsic value
- Well below intrinsic value
- Gap
- Can close
- AXPAmerican ExpressShares: Regulation and courts, Weak consumer
- Intrinsic value
- Below intrinsic value
- Gap
- Can close
Loading your notes…
Read it all? Star L or pass, then go on to the next one.